Losartan Global Market Report 2025

Description

Losartan is an angiotensin II receptor blocker (ARB) commonly prescribed to treat high blood pressure and reduce the risk of stroke in patients with hypertension. It works by relaxing blood vessels, which makes it easier for the heart to pump blood. Losartan helps lower blood pressure, improves heart function, and protects kidney health, particularly in patients with diabetes.

The primary forms of losartan dosage include tablets, powder, and suspension. Losartan tablets are convenient, once-daily oral medications used to manage hypertension and diabetic nephropathy. It is sourced from various suppliers, including contract manufacturing organizations and in-house production, and is distributed through both online and offline channels. Losartan is used for a range of conditions, including hypertension, stroke, diabetic nephropathy, and more. It is suitable for use by a variety of end-users, including both adults and pediatrics.

The losartan market research report is one of a series of new reports from The Business Research Company that provides losartan market statistics, including the losartan industry global market size, regional shares, competitors with the losartan market share, detailed losartan market segments, market trends, and opportunities, and any further data you may need to thrive in the losartan industry. This losartan market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The losartan market size has grown steadily in recent years. It will grow from $1.44 billion in 2024 to $1.50 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth during the historic period can be attributed to factors such as the increasing geriatric population, rising healthcare expenditure, a rise in diabetic nephropathy cases, greater awareness of blood pressure management, and the growing adoption of generic ARBs.

The losartan market size is expected to see steady growth in the next few years. It will grow to $1.79 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth during the forecast period can be attributed to factors such as the increasing demand for cost-effective antihypertensive drugs, a growing focus on preventive healthcare, the rising prevalence of lifestyle-related disorders, expanded healthcare access in emerging markets, and the continuous launch of generic formulations. Key trends during this period include advancements in drug delivery systems, the development of fixed-dose combination therapies, innovation in formulation technologies, improved manufacturing processes, and the development of personalized medicine approaches.

The growing prevalence of hypertension is expected to drive the expansion of the losartan market in the near future. Hypertension, characterized by persistently high blood pressure, increases the risk of heart disease, stroke, and other serious health issues. The rise in hypertension is often linked to diets rich in salt and processed foods, which cause fluid retention and increase the strain on the heart. Losartan helps manage hypertension by blocking angiotensin II, a hormone that narrows blood vessels. This action relaxes and widens the vessels, lowering blood pressure and reducing the heart's burden. For example, the American Heart Association reported that in January 2024, there were 131,454 deaths primarily associated with high blood pressure in 2022, an increase from 124,508 deaths in 2021. This rising prevalence of hypertension is driving the demand for losartan.

Major companies in the losartan market are focusing on creating innovative products to improve patient compliance and expand therapeutic uses. One such innovation is the losartan potassium oral suspension, a liquid form of losartan designed for people who find it difficult to swallow tablets. In March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received FDA approval for Arbli, a ready-to-use liquid formulation for treating hypertension, reducing stroke risk in hypertensive patients with left ventricular hypertrophy, and managing diabetic nephropathy in type 2 diabetes patients. Arbli offers precise dosing without the need for compounding and comes in a 165 mL peppermint-flavored suspension (10 mg/mL), with an 18-month shelf life at room temperature.

In April 2025, Scienture Holdings, Inc. formed a partnership with Saptalis Pharmaceuticals to manufacture Arbli, a losartan potassium oral suspension (10 mg/mL). This collaboration includes warehousing and distribution agreements with strategic partners to ensure the successful market launch of the first FDA-approved ready-to-use oral liquid losartan, addressing the unmet needs in hypertension treatment. Saptalis Pharmaceuticals, based in the United States, is a key partner in this initiative.

Major players in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

North America was the largest region in the losartan market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in losartan report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the losartan market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The losartan market consists of sales of losartan potassium tablets, losartan-hydrochlorothiazide combination tablets, and generic formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Losartan Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on losartan market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for losartan ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The losartan market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Dosage: Tablet; Powder; Suspension
2) By Source: Contract Manufacturing Organizations; In-House
3) By Distribution Channel: Online; Offline
4) By Application: Hypertension; Stroke; Diabetic Nephropathy; Other Applications
5) By End-User: Adult; Pediatric
Subsegments:
1) By Tablet: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)
2) By Powder: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)
3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL); 10 Milligrams (mg) Per 5 Milliliters (mL); 25 Milligrams (mg) Per 5 Milliliters (mL)
Companies Mentioned: Viatris Inc.; Teva Pharmaceutical Industries Ltd; Intas Pharmaceuticals Ltd.; Sun Pharmaceutical Industries Ltd.; Apotex Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35475

1. Executive Summary

2. Losartan Market Characteristics

3. Losartan Market Trends And Strategies

4. Losartan Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Losartan Growth Analysis And Strategic Analysis Framework

5.1. Global Losartan PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Losartan Market Growth Rate Analysis
5.4. Global Losartan Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Losartan Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Losartan Total Addressable Market (TAM)

6. Losartan Market Segmentation

6.1. Global Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablet
Powder
Suspension
6.2. Global Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Contract Manufacturing Organizations
In-House
6.3. Global Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online
Offline
6.4. Global Losartan Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypertension
Stroke
Diabetic Nephropathy
Other Applications
6.5. Global Losartan Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult
Pediatric
6.6. Global Losartan Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25 Milligrams (mg)
50 Milligrams (mg)
100 Milligrams (mg)
6.7. Global Losartan Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25 Milligrams (mg)
50 Milligrams (mg)
100 Milligrams (mg)
6.8. Global Losartan Market, Sub-Segmentation Of Suspension, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
5 Milligrams (mg) Per 5 Milliliters (mL)
10 Milligrams (mg) Per 5 Milliliters (mL)
25 Milligrams (mg) Per 5 Milliliters (mL)

7. Losartan Market Regional And Country Analysis

7.1. Global Losartan Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Losartan Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Losartan Market

8.1. Asia-Pacific Losartan Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Losartan Market

9.1. China Losartan Market Overview
9.2. China Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Losartan Market

10.1. India Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Losartan Market

11.1. Japan Losartan Market Overview
11.2. Japan Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Losartan Market

12.1. Australia Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Losartan Market

13.1. Indonesia Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Losartan Market

14.1. South Korea Losartan Market Overview
14.2. South Korea Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Losartan Market

15.1. Western Europe Losartan Market Overview
15.2. Western Europe Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Losartan Market

16.1. UK Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Losartan Market

17.1. Germany Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Losartan Market

18.1. France Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Losartan Market

19.1. Italy Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Losartan Market

20.1. Spain Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Losartan Market

21.1. Eastern Europe Losartan Market Overview
21.2. Eastern Europe Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Losartan Market

22.1. Russia Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Losartan Market

23.1. North America Losartan Market Overview
23.2. North America Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Losartan Market

24.1. USA Losartan Market Overview
24.2. USA Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Losartan Market

25.1. Canada Losartan Market Overview
25.2. Canada Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Losartan Market

26.1. South America Losartan Market Overview
26.2. South America Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Losartan Market

27.1. Brazil Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Losartan Market

28.1. Middle East Losartan Market Overview
28.2. Middle East Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Losartan Market

29.1. Africa Losartan Market Overview
29.2. Africa Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Losartan Market Competitive Landscape And Company Profiles

30.1. Losartan Market Competitive Landscape
30.2. Losartan Market Company Profiles
- 30.2.1. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Losartan Market Other Major And Innovative Companies

31.1. Aurobindo Pharma Ltd.
31.2. Dr. Reddy's Laboratories Ltd.
31.3. Cipla Ltd.
31.4. Cadila Pharmaceuticals Ltd.
31.5. Lupin Ltd.
31.6. Zydus Lifesciences Ltd.
31.7. Torrent Pharmaceuticals Ltd.
31.8. Alembic Pharmaceuticals Ltd.
31.9. Vasudha Pharma Chem Ltd.
31.10. Unichem Laboratories Ltd.
31.11. Global Pharma Tek
31.12. Manus Aktteva Biopharma LLP
31.13. Emcure Pharmaceuticals Ltd.
31.14. Wellona Pharma
31.15. JPM Pharma & Chemicals Pvt. Ltd.

32. Global Losartan Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Losartan Market

34. Recent Developments In The Losartan Market

35. Losartan Market High Potential Countries, Segments and Strategies

35.1 Losartan Market In 2029 - Countries Offering Most New Opportunities
35.2 Losartan Market In 2029 - Segments Offering Most New Opportunities
35.3 Losartan Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer